Mechanism of Action
Pure trans-isomer of clomiphene. Blocks estrogen receptors in the hypothalamus and pituitary, removing negative feedback and stimulating LH and FSH release. The absence of the zuclomiphene isomer eliminates the estrogenic activity that causes the mood side effects associated with standard Clomid. Produces comparable or superior LH stimulation with a cleaner side effect profile.
Ester Profile
Oral SERM. No ester. The separation from the zuclomiphene isomer eliminates the long-acting estrogenic component of standard Clomid. Half-life of 10-13 hours.
How It's Used in Fitness
Enclomiphene is used in PCT protocols as a cleaner alternative to standard Clomid. The LH stimulation is at least as effective as Clomid while avoiding the mood dysregulation that makes standard Clomid PCT difficult for many users. It is also increasingly used as a standalone treatment for secondary hypogonadism — maintaining testosterone levels without shutting down fertility the way TRT does. This makes it valuable for athletes who want to maintain testosterone function between cycles without committing to exogenous testosterone.
Stacking Context
Enclomiphene is used in PCT alongside Tamoxifen in the same way standard Clomid is — as a combination SERM protocol for HPT axis recovery. It can replace Clomid directly in any PCT protocol. It is also used as a standalone maintenance compound between cycles by athletes who want to preserve fertility and natural testosterone function.
Medical Use
- Male hypogonadotropic hypogonadism
- Male infertility — being developed as an FDA-approved treatment
- Phase III trials completed for secondary hypogonadism in men
Side Effects
- Mild vision disturbances — less common than standard Clomid
- Hot flashes
- Mood changes — milder than standard Clomid
- Headache
- Suboptimal LH to FSH ratio in some individuals
- Limited availability and higher cost than standard Clomid
What Actually Goes Wrong
Enclomiphene is significantly better tolerated than standard Clomid for most users. The vision disturbances and severe mood effects that characterize standard Clomid PCT are substantially reduced. The remaining risks are the standard SERM risks — some estrogenic effects, the LH-to-FSH ratio consideration, and the WADA ban that applies to all SERMs. Availability is more limited than standard Clomid because it is not yet widely approved.
Detection Window
WADA bans all SERMs. Enclomiphene and metabolites detectable for weeks.
Enclomiphene is what Clomid should have been. The zuclomiphene isomer in standard Clomid was never the active component for LH stimulation — it only contributed side effects. If you have access to pharmaceutical-grade enclomiphene, it is a straightforward upgrade from standard Clomid in PCT protocols. The barrier is availability and cost rather than any pharmacological reason to prefer standard Clomid.